Dr. Marty Makary

Yeah.

Well, one thing that is a theme in Blind Spots and a theme in the research I learned was that if somebody put something out there with such absolutism, when the scientific evidence is really inconclusive or there's a lot of opinion, we just don't know what the long-term effects of GLP-1 are, for example. They just haven't been around long enough.

Well, one thing that is a theme in Blind Spots and a theme in the research I learned was that if somebody put something out there with such absolutism, when the scientific evidence is really inconclusive or there's a lot of opinion, we just don't know what the long-term effects of GLP-1 are, for example. They just haven't been around long enough.

Well, one thing that is a theme in Blind Spots and a theme in the research I learned was that if somebody put something out there with such absolutism, when the scientific evidence is really inconclusive or there's a lot of opinion, we just don't know what the long-term effects of GLP-1 are, for example. They just haven't been around long enough.

How can you say with such absolutism that there's no long-term downside? We may see a benefit in the short term with some of these chronic diseases, but we may be accelerating frailty, which is basically loss of muscle mass. And that is, as you know, the number one predictor of longevity is muscle mass. And that's why we want people to be active when they're older.

How can you say with such absolutism that there's no long-term downside? We may see a benefit in the short term with some of these chronic diseases, but we may be accelerating frailty, which is basically loss of muscle mass. And that is, as you know, the number one predictor of longevity is muscle mass. And that's why we want people to be active when they're older.

How can you say with such absolutism that there's no long-term downside? We may see a benefit in the short term with some of these chronic diseases, but we may be accelerating frailty, which is basically loss of muscle mass. And that is, as you know, the number one predictor of longevity is muscle mass. And that's why we want people to be active when they're older.

So we don't have that data and people are acting as if it doesn't matter. It'll go the way we want it to go. There are bacteria in the microbiome that produce GLP-1. Yeah. And maybe we should be talking more about- Probiotics. Having a very healthy- There is one. Yeah, maybe we- There is one. You already make some. So it's like, how can we not crush that?

So we don't have that data and people are acting as if it doesn't matter. It'll go the way we want it to go. There are bacteria in the microbiome that produce GLP-1. Yeah. And maybe we should be talking more about- Probiotics. Having a very healthy- There is one. Yeah, maybe we- There is one. You already make some. So it's like, how can we not crush that?

So we don't have that data and people are acting as if it doesn't matter. It'll go the way we want it to go. There are bacteria in the microbiome that produce GLP-1. Yeah. And maybe we should be talking more about- Probiotics. Having a very healthy- There is one. Yeah, maybe we- There is one. You already make some. So it's like, how can we not crush that?

We're on a path of having every eight-year-old in America on three or four medications. It's scary.

We're on a path of having every eight-year-old in America on three or four medications. It's scary.

We're on a path of having every eight-year-old in America on three or four medications. It's scary.

When they're children.

When they're children.

When they're children.

I mean, already half of America are taking chronic medications and the average number is four. Once you get over 65, it's like you got to have these boxes to remember what to take. And look, medications save lives. You and I have seen that. That's part of the medicine we're trained in. We're going to convert America's children into a generation of patients.

I mean, already half of America are taking chronic medications and the average number is four. Once you get over 65, it's like you got to have these boxes to remember what to take. And look, medications save lives. You and I have seen that. That's part of the medicine we're trained in. We're going to convert America's children into a generation of patients.

I mean, already half of America are taking chronic medications and the average number is four. Once you get over 65, it's like you got to have these boxes to remember what to take. And look, medications save lives. You and I have seen that. That's part of the medicine we're trained in. We're going to convert America's children into a generation of patients.

Maybe we need to talk more about school lunch programs than putting every kid on Ozempic. And that is not a conversation that we're having. We're just sort of celebrating, hey, high five. We found a way to create a GLP-1 agonist. We'll see about these new generation GLP-1 drugs that have a blocker on the muscle receptor, supposedly. They're going to enter clinical trial soon. Yeah.